 BILLERICA, Mass.--BUSINESS WIRE--Quanterix Corporation NASDAQ: QTRX, a company digitizing biomarker analysis to advance the science of precision health, today released the following statement in response to news reports related to Cassava Sciences. Cassava previously engaged Quanterix Accelerator laboratory to perform sample testing based on blinded samples provided by Cassava. Quanterix or its employees did not interpret the test results or prepare the data charts presented by Cassava at 